Cost-Effectiveness Comparison of Ustekinumab, Infliximab, or Adalimumab for the Treatment of Moderate-Severe Crohn's Disease in Biologic-Naïve Patients
Author:
Affiliation:
1. Leonard D. Schaeffer Center for Health Policy & Economics; Los Angeles California
2. Inflammatory Bowel Disease Center; Division of Gastrointestinal and Liver Disease; USC/Keck School of Medicine; Los Angeles California
Publisher
Wiley
Subject
Pharmacology (medical)
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/phar.2208/fullpdf
Reference36 articles.
1. Crohn's disease;Baumgart;Lancet,2012
2. Crohn's disease;Kalla;BMJ,2014
3. Management of Crohn's disease in adults;Lichtenstein;Am J Gastroenterol,2009
4. Natural history and long-term clinical course of Crohn's disease;Freeman;World J Gastroenterol,2014
5. The cost of Crohn's disease: varied health care expenditure patterns across distinct disease trajectories;Rao;Inflamm Bowel Dis,2017
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Simulated cost‐effectiveness of a novel precision‐guided dosing strategy in adult patients with Crohn's disease initiating infliximab maintenance therapy;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-04
2. Clinical Outcomes of Ustekinumab in Inflammatory Bowel Disease;Cureus;2023-10-11
3. A Systematic Literature Review of Gaps and Challenges in Value Assessment of Biosimilars: An ISPOR Special Interest Group Report;Value in Health;2023-08
4. Infliximab Pricing in International Economic Evaluations in Inflammatory Bowel Disease to Inform Biologic and Biosimilar Access Policies: A Systematic Review;MDM Policy & Practice;2023-01
5. Adalimumab vs Infliximab in Pediatric Patients With Crohn's Disease: A Propensity Score Analysis and Predictors of Treatment Escalation;Clinical and Translational Gastroenterology;2022-04-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3